Article Sidebar

PDF
Issue: Vol. 563 No. 3 (2026)
Section: Các bài báo
DOI: 10.51298/vmj.v563i3.19145
Date Published: 08/10/2026
Views 0
Downloads 0
How to Cite
Chu, V. T., & Dương, H. T. (2026). RATE OF RECURRENT BLEEDING DUE TO ESOPHAGEAL VENOUS RUPTURE AND SOME RELATED FACTORS IN CIRRHOSIS PATIENTS TREATED WITH PROPRANOLOLE COMBINED WITH RUBBER BANDAGE LIGAMENT IN TUYEN QUANG. Vietnam Medical Journal, 563(3). https://doi.org/10.51298/vmj.v563i3.19145

RATE OF RECURRENT BLEEDING DUE TO ESOPHAGEAL VENOUS RUPTURE AND SOME RELATED FACTORS IN CIRRHOSIS PATIENTS TREATED WITH PROPRANOLOLE COMBINED WITH RUBBER BANDAGE LIGAMENT IN TUYEN QUANG

Văn Tuân Chu1, , Hồng Thái Dương2
1 Bệnh viện Đa khoa tỉnh Tuyên Quang
2 Trường Đại học Y Dược - Đại học Thái Nguyên

Main Article Content

Abstract

Objective: The rate of recurrent bleeding and analysis of some factors related to recurrent bleeding in cirrhotic patients treated with Propranolol combined with rubber band ligation at Tuyen Quang Provincial General Hospital in 2025-2026.


Subjects: Eighty-six cirrhotic patients with ruptured esophageal varices were treated with Propranolol combined with rubber band ligation at the Internal Medicine Department of Tuyen Quang Provincial General Hospital.


Method: Cross-sectional descriptive study.


Results: The recurrence rate was 26,7% (including 10,4% mortality). Several factors associated with the risk of recurrent bleeding in this study included:    Factors included alcoholic cirrhosis (OR=0,2; 95%CI: 0,04-0,92), grade III esophageal varices (OR=7,8; 95%CI:1,09-55,57), diffuse esophageal varices (OR=8,8; 95%CI:0,62-17,34), continued alcohol consumption after treatment (OR=5,4; 95%CI: 1,04-28,39), and irregular or non-adherence to Propranolol therapy (OR=0,1; 95%CI: 0,01-0,5).


Conclusion: The rate of recurrent bleeding within six months was 26.7%. Risk factors for recurrent bleeding included alcoholic cirrhosis, grade III esophageal varices, diffuse esophageal varices, continued alcohol consumption after treatment, and irregular or non-adherence to Propranolol therapy.

Keywords

cirrhosis due to esophageal variceal rupture, recurrent bleeding, risk factors

Article Details

References

1. Molleston, J. P. & Bennett Jr, W. E. J. T. J. o. P (2021). Mortality, risk factors and disparities associated with esophageal variceal bleeding in children’s hospitals in the US. 232, 176-182.
2. De Mattos, Â. Z., Terra, C., Farias, A. Q. & Bittencourt, P. L. J. W. J. o. G. E (2021). Primary prophylaxis of variceal bleeding in patients with cirrhosis: A comparison of different strategies. 13, 628.
3. Funakoshi, N. et al (2010). Benefit of combination β-blocker and endoscopic treatment to prevent variceal rebleeding: a meta-analysis. 16, 5982.
4. Cho, H. et al (2016). Recurrence and prognosis of patients emergently hospitalized for acute esophageal variceal bleeding: A long-term cohort study. 46, 1338-1346.
5. Salman, A. et al (2020). Long-term outcome after endoscopic ligation of acute esophageal variceal bleeding in patients with liver cirrhosis. 83.
6. Yaru, H. et al (2022). Predictive factors for re-bleeding of esophageal varices in hospitalized patients. 68, 183-188.
7. Drolz, A. et al (2021). Risk factors associated with bleeding after prophylactic endoscopic variceal ligation in cirrhosis. 53, 226-234.
8. Saleem, K. et al (2022). The Predictors Of Re-Bleeding In Chronic Liver Disease Patients After Endoscopic Variceal Band Ligation. 34.